Panacea Biotec Stock Screener | Share Price & Fundamental Analysis
PANACEABIO
Pharmaceuticals
Share Price NSE
₹347.55
▼
-6.20 (-1.75%)
Share Price BSE
₹347.85
▼
-6.85 (-1.93%)
Track Panacea Biotec share price live with TickJournal's free stock screener.
Analyze Panacea Biotec share price history trends and compare 52-week high low
levels.
Calculate PANACEABIO stock fair value using fundamental analysis and view live share price charts.
Determine Panacea Biotec share intrinsic value and compare it with current PANACEABIO share price.
Record your Panacea Biotec trades in TickJournal's free trading journal and track your portfolio performance.
Panacea Biotec Market Cap
₹2,146.53 Cr.
PANACEABIO P/E Ratio (TTM)
-266.69
EPS (TTM)
₹-1.37
Dividend Yield
-
Debt to Equity
0.02
PANACEABIO 52 Week High
₹566.20
Panacea Biotec 52 Week Low
₹320.40
Operating Margin
7.00%
Profit Margin
2.35%
PANACEABIO Revenue (TTM)
₹170.00
EBITDA
₹17.00
Net Income
₹4.00
Total Assets
₹1,290.00
Total Equity
₹831.00
Panacea Biotec Share Price History - Stock Screener Chart
Screen PANACEABIO historical share price movements with interactive charts. Analyze price trends and patterns.
Panacea Biotec Company Profile - Fundamental Screener
Screen Panacea Biotec company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for PANACEABIO shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE922B01023
Panacea Biotec Balance Sheet Screener
Screen PANACEABIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,290 | 1,241 | 1,271 | 1,759 | 1,178 | 1,390 | 1,376 | 1,608 | 1,800 | 1,854 |
| Current Assets | 545 | 486 | 562 | 951 | 511 | 683 | 508 | 560 | 533 | 549 |
| Fixed Assets | 567 | 582 | 600 | 622 | 609 | 657 | 806 | 949 | 1,001 | 1,071 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 92 | 94 | 99 | 109 | 960 | 743 | 90 | 611 | 846 | 930 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 831 | 838 | 840 | 874 | -232 | 196 | 347 | 306 | 366 | 450 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 22 |
| Reserves & Surplus | 807 | 814 | 816 | 849 | -257 | 139 | 335 | 293 | 340 | 426 |
Panacea Biotec Income Statement Screener - Profit & Revenue Analysis
Screen Panacea Biotec income statement and profit fundamentals.
Analyze PANACEABIO quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Panacea Biotec share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 170 | 150 | 184 | 169 | 170 | 155 | 122 | 150 | 159 | 149 | 163 | 163 | 157 | 143 | 151 |
| Expenses | 153 | 159 | 168 | 159 | 156 | 140 | 130 | 143 | 151 | 147 | 140 | 135 | 124 | 109 | 191 |
| EBITDA | 17 | -9 | 16 | 9 | 14 | 14 | -8 | 8 | 8 | 2 | 24 | 29 | 33 | 34 | -40 |
| Operating Profit % | 7.00% | -13.00% | -1.00% | -20.00% | 5.00% | 5.00% | -12.00% | -4.00% | 0.00% | -2.00% | -8.00% | -4.00% | -8.00% | -4.00% | -72.00% |
| Depreciation | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 10 | 10 |
| Interest | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 7 | -19 | 7 | 0 | 4 | 5 | -17 | -2 | -2 | -8 | 13 | 18 | 22 | 23 | -51 |
| Tax | 3 | -5 | 3 | 2 | 0 | 0 | -1 | 0 | 1 | 1 | 2 | 31 | 3 | 8 | 5 |
| Net Profit | 4 | -14 | 4 | -2 | 4 | 5 | -16 | -2 | -2 | -8 | 11 | -13 | 19 | 16 | -56 |
| EPS | 0.65 | -2.27 | 0.66 | -0.31 | 0.74 | 0.77 | -2.59 | -0.23 | -0.37 | -1.35 | 1.79 | -2.03 | 3.16 | 2.56 | -9.17 |
Panacea Biotec Cash Flow Screener - Liquidity Fundamentals
Screen PANACEABIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -27 | 4 | -423 | -108 | 107 | -31 | 105 | 118 | 131 | 91 |
| Investing Activities | 65 | 7 | 430 | 1,283 | -48 | -35 | -6 | 55 | -26 | 17 |
| Financing Activities | -3 | -3 | -18 | -1,176 | -47 | 91 | -101 | -164 | -107 | -117 |
| Net Cash Flow | 35 | 7 | -11 | -2 | 12 | 26 | -2 | 9 | -2 | -10 |
Panacea Biotec Shareholding Pattern Screener
See Panacea Biotec shareholding pattern with promoter, FII, and DII holdings.
Check Panacea Biotec promoter holding and ownership changes for PANACEABIO on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.48% | 72.48% | 72.48% | 72.48% | 73.59% | 73.46% | 72.87% | 72.49% |
| FII Holding | 1.16% | 0.78% | 1.06% | 1.36% | 0.27% | 0.27% | 0.37% | 0.38% |
| DII Holding | 1.49% | 1.52% | 1.81% | 1.85% | 0.84% | 1.07% | 1.16% | 1.17% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 18.45% | 18.17% | 17.69% | 17.49% | 19.90% | 20.42% | 18.11% | 18.98% |
| Other Holding | 6.41% | 7.05% | 6.96% | 6.81% | 5.40% | 4.79% | 7.49% | 6.99% |
| Shareholder Count | 33,593 | 34,256 | 33,593 | 34,597 | 46,242 | 45,513 | 39,982 | 35,446 |
Panacea Biotec Share Dividend Screener - Share Yield Analysis
Check Panacea Biotec dividend history with payout and yield data.
View Panacea Biotec dividend details including ex-dates and amounts for PANACEABIO stock.
Panacea Biotec Stock Index Membership
See which indices include Panacea Biotec stock.
Check PANACEABIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Panacea Biotec Market Events Screener - Corporate Actions
Get Panacea Biotec corporate actions including splits, bonuses, and buybacks.
Check Panacea Biotec stock events that may affect PANACEABIO share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -4.67% | ||
| Annual General Meeting | NA | -17.99% | ||
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | 2.36% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -6.47% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 7.49% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -1.52% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 5.62% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 12.32% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 0.00% |
Panacea Biotec Competitors Screener - Peer Comparison
Screen PANACEABIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 438,574 | 39.72 | 54,729 | 9.71% | 10,980 | 68.53 |
| Divis Laboratories | 170,218 | 68.23 | 9,712 | 18.67% | 2,191 | 54.94 |
| Torrent Pharmaceuticals | 150,473 | 65.93 | 11,539 | 6.99% | 1,911 | 67.69 |
| Dr Reddys Laboratories | 110,689 | 19.86 | 33,741 | 16.73% | 5,725 | 59.67 |
| Lupin | 107,805 | 22.91 | 22,910 | 13.74% | 3,306 | 65.36 |
| Cipla | 107,676 | 23.75 | 28,410 | 7.12% | 5,291 | 45.99 |
| Zydus Life Science | 93,338 | 18.48 | 23,511 | 18.55% | 4,615 | 55.14 |
| Mankind Pharma | 92,728 | 51.23 | 12,744 | 20.90% | 2,007 | 59.18 |
| Aurobindo Pharma | 76,201 | 21.43 | 32,346 | 9.43% | 3,484 | 67.28 |
| Alkem Laboratories | 66,950 | 27.73 | 13,458 | 3.70% | 2,216 | 51.57 |
Panacea Biotec Company Announcements - News Screener
Screen PANACEABIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR Regulations) - Update On Ongoing Tax Litigation Reported Under Integrated Filing (Governance) | View | |
| 2026-03-08 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2026-03-07 | Demat Status Report For The Month Of February 2026 | View |
| 2026-03-03 | Receipt Of Demand Order From The Office Of The Deputy Commissioner Of Income Tax Delhi | View |
| 2026-02-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-11 | Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31 2025 | View |
| 2026-02-11 | Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31 2025 | View |
| 2026-02-06 | Details Of Shares Dematerialized During January 2026 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations 2018 | View |
| 2026-02-05 | Outcome Of Inspection By National Centre For Public Health And Pharmacy Hungary At Manufacturing Facility Of Panacea Biotec Pharma Limited At Baddi Himachal Pradesh | View |
| 2026-02-02 | Board Meeting Intimation for Approval Of Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter And Nine Months Ended December 31 2025 | View |
| 2026-01-07 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2026-01-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2026-01-07 | Details Of Shares Dematerialized During December 2025 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations 2018 | View |
| 2025-12-26 | Intimation Regarding Receipt Of Demand Order | View |
| 2025-12-26 | Closure of Trading Window | View |
| 2025-12-24 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-12-15 | Authorization Of Key Managerial Personnel For The Purpose Of Determining Materiality Of An Event Or Information &Making Disclosures To The Stock Exchange(S) Under The SEBI LODR Regulations | View |
| 2025-12-15 | Appointment of Company Secretary and Compliance Officer | View |
| 2025-12-15 | Announcement under Regulation 30 (LODR)-Cessation | View |